TrialClinical and translational science2020

A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer.

Adrian G Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.